Eflumenibep alfa Biosimilar – Research Grade from ProteoGenix; catalogue PX-TA2470; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Eflumenibep alfa Biosimilar – Research Grade is a cutting-edge biotech product that offers a highly effective and cost-efficient solution for researchers in the field of biotechnology. This biosimilar is a recombinant protein that is identical to the original Eflumenibep alfa, making it an ideal tool for a wide range of research applications.
Eflumenibep alfa is a protein that plays a crucial role in the regulation of the immune system. It belongs to the family of cytokines known as interferons, which are essential for the body’s natural defense against viruses and other pathogens. Eflumenibep alfa works by binding to specific receptors on cells, triggering a cascade of immune responses that help fight off infections and diseases.
Eflumenibep alfa Biosimilar – Research Grade is primarily used in research settings to study the mechanisms of the immune system and its role in various diseases. It can be used to investigate the effects of Eflumenibep alfa on different cell types, as well as its interactions with other proteins and molecules. This biosimilar is also commonly used in pre-clinical studies to evaluate the potential therapeutic benefits of Eflumenibep alfa in treating various diseases.
Eflumenibep alfa Biosimilar – Research Grade has been successfully used in a variety of research studies, including those focused on cancer, autoimmune diseases, and viral infections. In one study, Eflumenibep alfa was shown to have potent anti-tumor effects, making it a promising candidate for cancer therapy. Another study demonstrated its potential for treating autoimmune diseases by regulating the immune response. Additionally, Eflumenibep alfa has been shown to have antiviral properties, making it a valuable tool for studying viral infections.
With its high purity, consistency, and reliability, Eflumenibep alfa Biosimilar – Research Grade is a top choice for researchers looking to study the biological functions and potential therapeutic applications of Eflumenibep alfa. Its affordable price and ease of use make it accessible to a wide range of research labs, making it a valuable asset in the pursuit of scientific breakthroughs.
In summary, Eflumenibep alfa Biosimilar – Research Grade is a biotech product that offers researchers a powerful tool for studying the immune system and its potential therapeutic applications. Its biological function, main applications, and successful use cases make it a highly sought-after biosimilar in the biotechnology industry. Get your hands on Eflumenibep alfa Biosimilar – Research Grade today and take your research to the next level.
ProteoGenix catalogue number PX-TA2470. For research use only.
Target: Eflumenibep alfa Biosimilar – Research Grade; Host: Mammalian cells; Clonality: Monoclonal antibody; Expression system: Mammalian; Purity: >95% as determined by SDS-PAGE; Buffer: 0.01 M PBS pH 7.4.
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
